ReviewInfection and drug resistance2025
Advances in the Study of Acute Necrotizing Encephalopathy.
Review in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Reversible Central Sleep Apnea in Acute Necrotizing Encephalopathy of Childhood: A Case Report.Cureus · 2026Article
- Article
- Clinical features and outcomes of nine children with acute necrotizing encephalopathy.Frontiers in pediatrics · 2025Article
- Clinical features, prognostic factors of pediatric acute necrotizing encephalopathy: a 67-case retrospective analysis.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute necrotizing encephalopathy (ANE) is a rare and rapidly progressing acute encephalopathy characterized by seizures and changes in consciousness. This condition typically affects the thalamus, brainstem, and cerebellum in a symmetrical manner, and if left untreated, is associated with significantly higher mortality rates. In recent years, with in-depth research on the etiology and pathogenesis of ANE, as well as continuous advances in clinical diagnosis and treatment techniques, the understanding of this disease has gradually increased. However, the complexity and diversity of ANE still pose significant challenges to clinical diagnosis and treatment. In addition, due to its rarity, many clinical doctors have insufficient understanding of it, resulting in a high rate of misdiagnosis and missed diagnosis. Therefore, this article reviews the etiology, pathogenesis, risk factors, pathology, clinical manifestations, auxiliary examinations, diagnostic methods, treatment strategies, and prognosis related to ANE. Its purpose is to enhance clinical doctors' ability to identify and manage ANE, provide reference for accurate diagnosis and effective treatment, and support ongoing research aimed at gaining a deeper understanding of this serious disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.